| Literature DB >> 31626293 |
Vered Shani1, Hazem Safory1, Raymonde Szargel1, Ninghan Wang2, Tsipora Cohen1, Fatimah Abd Elghani1, Haya Hamza1, Mor Savyon1, Inna Radzishevsky1, Lihi Shaulov1, Ruth Rott1, Kah-Leong Lim3, Christopher A Ross4, Rina Bandopadhyay5, Hui Zhang2, Simone Engelender1.
Abstract
Mutations in LRRK2 cause autosomal dominant and sporadic Parkinson's disease, but the mechanisms involved in LRRK2 toxicity in PD are yet to be fully understood. We found that LRRK2 translocates to the nucleus by binding to seven in absentia homolog (SIAH-1), and in the nucleus it directly interacts with lamin A/C, independent of its kinase activity. LRRK2 knockdown caused nuclear lamina abnormalities and nuclear disruption. LRRK2 disease mutations mostly abolish the interaction with lamin A/C and, similar to LRRK2 knockdown, cause disorganization of lamin A/C and leakage of nuclear proteins. Dopaminergic neurons of LRRK2 G2019S transgenic and LRRK2 -/- mice display decreased circularity of the nuclear lamina and leakage of the nuclear protein 53BP1 to the cytosol. Dopaminergic nigral and cortical neurons of both LRRK2 G2019S and idiopathic PD patients exhibit abnormalities of the nuclear lamina. Our data indicate that LRRK2 plays an essential role in maintaining nuclear envelope integrity. Disruption of this function by disease mutations suggests a novel phosphorylation-independent loss-of-function mechanism that may synergize with other neurotoxic effects caused by LRRK2 mutations.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31626293 PMCID: PMC7335485 DOI: 10.1093/hmg/ddz245
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150